Diel
IJ et al. Bisphosphonates and the prevention of metastasis:
first evidences from preclinical and clinical studies. Cancer
2000;88(12 Suppl):3080-8.
Diel IJ,
Mundy GR. Bisphosphonates in the adjuvant treatment of cancer:
experimental evidence and first clinical results. International
Bone and Cancer Study Group (IBCG).
Br J Cancer 2000;82(8):1381-6.
Diel IJ.
Antitumour effects of bisphosphonates: first evidence and
possible mechanisms.
Drugs 2000 ;59(3):391-9.
Diel IJ
et al. Reduction in new metastases in breast cancer with adjuvant
clodronate treatment. N
Engl J Med 1998;339(6):357-63.
Powles
TJ et al. Adjuvant clodronate reduces the incidence of bone
metastases in patients with primary operable breast cancer.
Proc
ASCO 1998;Abstract 468.
Saarto
T et al. Adjuvant Clodronate Treatment Does Not Reduce the
Frequency of Skeletal Metastases in Node-Positive Breast Cancer
Patients: 5-Year Results of a Randomized Controlled Trial.
J
Clin Oncol;2001:10-17.
|
